<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412018000200005</article-id>
<article-id pub-id-type="doi">10.24245/gom.v86i2.1881</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia]]></article-title>
<article-title xml:lang="en"><![CDATA[Estriol vs. Conjugated estrogens of equine origin in the treatment of the genitourinary syndrome of menopause]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espitia-De La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orozco-Gallego]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Clínica La Sagrada Familia Servicio de Ginecología y Uroginecología ]]></institution>
<addr-line><![CDATA[Armenia Quindío]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Tecnológica de Pereira Departamento de Física ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2018</year>
</pub-date>
<volume>86</volume>
<numero>2</numero>
<fpage>117</fpage>
<lpage>126</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412018000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412018000200005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412018000200005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  OBJETIVO  Comparar la efectividad y seguridad del estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia.  MATERIALES Y MÉTODOS  Ensayo clínico multicéntrico, doble ciego, controlado, con asignación al azar, efectuado en tres clínicas de Colombia entre los meses de julio de 2015 y septiembre de 2017. Criterio de inclusión: mujeres con síndrome genitourinario de la menopausia tratadas con estrógenos tópicos. Las pacientes se asignaron al azar a dos grupos: A (estriol) y B (estrógenos conjugados de origen equino). Variables de estudio: concentraciones séricas de estradiol, testosterona total, globulina fijadora de hormonas sexuales, porcentaje de satisfacción al disminuir los síntomas y tiempo hasta su desaparición. También se consideraron: pH vaginal menor de 4.5, puntuación del índice de maduración vaginal, intensidad de la sequedad vaginal, necesidad de terapia hormonal sistémica, medición del endometrio, comportamiento sexual y coexistencia de efectos secundarios.  RESULTADOS  Se estudiaron 387 mujeres: 192 del grupo A, que recibió estriol y 195 del grupo B tratadas con estrógenos conjugados de origen equino. El porcentaje de efectividad en el grupo A fue de 90.6% y en el grupo B de 89.2%; (p = 0.507). Las mujeres del grupo A experimentaron menos efectos secundarios (26.5%) que las del grupo B (38.4%). En las otras variables no se encontraron diferencias.  CONCLUSIONES  El estriol y los estrógenos conjugados de origen equino son igual de efectivos y seguros para tratar el síndrome genitourinario de la menopausia; sin embargo, el estriol ofrece mayores ventajas porque disminuye más rápidamente los síntomas y origina menores efectos secundarios.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  OBJECTIVE  To compare the effectiveness and safety of estriol vs. conjugated estrogens of equine origin in the treatment of the genitourinary syndrome of menopause.  MATERIALS AND METHODS  Multicentric, double-blind, controlled, randomized clinical trial conducted in three clinics in Colombia between July 2015 and September 2017. Inclusion criteria: women with menopausal genitourinary syndrome treated with topical estrogens. The patients were randomly assigned to two groups: A (estriol) and B (conjugated estrogens of equine origin). Study variables: serum levels of estradiol, total testosterone, sex hormone-binding globulin, percentage of satisfaction with decreasing symptoms and time to disappearance. The following were also considered: vaginal pH lower than 4.5, vaginal maturation index score, intensity of vaginal dryness, need for systemic hormonal therapy, measurement of the endometrium, sexual behavior and coexistence of side effects.  RESULTS  We studied 387 women: 192 of group A, who received estriol and 195 of group B treated with conjugated estrogens of equine origin. The percentage of effectiveness in group A was 90.62% and in group B it was 89.23%; (p = 0.507). In women in group A there were fewer side effects (26.56%) than in group B (38.46%). No differences were found in the other variables.  CONCLUSIONS  Estriol and conjugated estrogens of equine origin are equally effective and safe in the treatment of the genitourinary syndrome of menopause.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Menopausia]]></kwd>
<kwd lng="es"><![CDATA[estriol]]></kwd>
<kwd lng="es"><![CDATA[estrógenos conjugados]]></kwd>
<kwd lng="es"><![CDATA[equinos]]></kwd>
<kwd lng="es"><![CDATA[sequedad vaginal]]></kwd>
<kwd lng="en"><![CDATA[Menopause]]></kwd>
<kwd lng="en"><![CDATA[Estriol]]></kwd>
<kwd lng="en"><![CDATA[Conjugated estrogens]]></kwd>
<kwd lng="en"><![CDATA[Equine]]></kwd>
<kwd lng="en"><![CDATA[Vaginal dryness]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Portman]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gass]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genitourinary syndrome of menopause new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2014</year>
<volume>21</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia de La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco Gallego]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia; actualización]]></article-title>
<source><![CDATA[]]></source>
<year>2017</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>7:67-84</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palacios]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Managing urogenital atrophy]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2009</year>
<volume>63</volume>
<page-range>315-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DiBonaventura]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Moffatt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bushmakin]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bobula]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe]]></article-title>
<source><![CDATA[J Womens Health (Larchmt)]]></source>
<year>2015</year>
<volume>24</volume>
<page-range>713-22</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calleja-Agius]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Brincat]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urogenital atrophy]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2009</year>
<volume>12</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>279-85</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Panay]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genitourinary syndrome of the menopause -dawn of a new era]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2015</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bachmann]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vulvovaginal complaints]]></article-title>
<source><![CDATA[Clin Obstet Gynecol]]></source>
<year>2008</year>
<volume>51</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>549-55</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Portman]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gass]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vulvovaginal Atrophy Terminology Consensus Conference Panel Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2014</year>
<volume>21</volume>
<page-range>1063-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nappi]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Palacios]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2014</year>
<volume>17</volume>
<page-range>3-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>The North American Menopause Society</collab>
<article-title xml:lang=""><![CDATA[Management of symptomatic vulvovaginal atrophy 2013 position statement of The North American Menopause Society]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2013</year>
<volume>20</volume>
<page-range>888-902</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bachmann]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hoppe]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2009</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>719-27</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nachtigall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ulrich]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Eugster-Hausmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gut]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometrial safety of ultra-low-dose estradiol vaginal tablets]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2010</year>
<volume>116</volume>
<page-range>876-83</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bennink]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reprint of Are all estrogens the same]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2008</year>
<volume>61</volume>
<page-range>195-201</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McEndree]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical application of the vaginal maturation index]]></article-title>
<source><![CDATA[Nurse Pract]]></source>
<year>1999</year>
<volume>24</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>48</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van der Laak]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Schijf]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Kerstens]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Heijnen-Wijnen]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[de Wilde]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Hanselaar]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and validation of a computerized cytomorphometric method to assess the maturation of vaginal epithelial cells]]></article-title>
<source><![CDATA[Cytometry]]></source>
<year>1999</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>196-202</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meisels]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Maturation value]]></article-title>
<source><![CDATA[Acta Cytol]]></source>
<year>1967</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>249</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brizzolara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Killeen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Severino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vaginal pH and parabasal cells in postmenopausal women]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>1999</year>
<volume>94</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>700-3</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Willhite]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[O'Connell]]></surname>
<given-names><![CDATA[M. B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urogenital atrophy: prevention and treatment]]></article-title>
<source><![CDATA[Pharmacotherapy]]></source>
<year>2001</year>
<volume>21</volume>
<page-range>464-80</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carranza-Lira]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fragoso-Díaz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[MacGregor-Gooch]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Garduño-Hernández]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Ríos-Calderón]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vaginal dryness assessment in postmenopausal women using pH test strip]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2003</year>
<volume>45</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>55-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santen]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pinkerton]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Conaway]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of urogenital atrophy with low-dose estradiol preliminary results]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2002</year>
<volume>9</volume>
<page-range>179-87</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bachmann]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Gut]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Nachtigall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Notelovtz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis A randomised controlled trial]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2008</year>
<volume>111</volume>
<page-range>67-76</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eugster-Mausmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Waitzinger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lehnick]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Minimized estradiol absorption with ultra-low dose 10 mcg 17 b-estradiol vaginal tablets]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2010</year>
<volume>13</volume>
<page-range>219-27</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dorr]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Mayer]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis]]></article-title>
<source><![CDATA[Fertil Steril]]></source>
<year>2010</year>
<volume>94</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2365-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nachtigall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gut]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Utian]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2008</year>
<volume>112</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1053-60</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suckling]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lethaby]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Local oestrogen for vaginal atrophy in postmenopausal women]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2006</year>
<volume>4</volume>
<page-range>CD001500</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sturdee]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Panay]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations for the management of postmenopausal vaginal atrophy]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2010</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>509-22</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia-De La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco Gallego]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverri Ocampo]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapia hormonal y no hormonal en la vaginitis atrófica posmenopáusica cura y satisfacción a mediano y a largo plazo de los síntomas]]></article-title>
<source><![CDATA[Rev. Col. de menopausia]]></source>
<year>2016</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-17</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahn]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Carberry]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sanses]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Mamik]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Meriwether]]></surname>
<given-names><![CDATA[KV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vaginal estrogen for genitourinary syndrome of menopause a systematic review]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2014</year>
<volume>124</volume>
<page-range>1147-56</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Panay]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hamoda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Arya]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Savvas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 2013 British Menopause Society &amp; Women's Health Concern recommendations on hormone replacement therapy]]></article-title>
<source><![CDATA[Menopause Int]]></source>
<year>2013</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>59-68</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Eyster]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What Happened to WHI Menopausal Hormonal Therapy in 2012]]></article-title>
<source><![CDATA[Clin Obstet Gynecol]]></source>
<year>2012</year>
<volume>55</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>706-12</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Griesser]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Skonietzki]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Fielder]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Suesskind]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low dose estriol pessaries for the treatment of vaginal atrophy A double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2 mg and 0.03 mg estriol]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2012</year>
<volume>71</volume>
<page-range>360-8</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granberg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wikland]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Karlsson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Norström]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Friberg]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>1991</year>
<volume>164</volume>
<page-range>47-52</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
